+
Site Tour

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

An analysis was performed on real-world outcomes of U.S. Medicare beneficiaries >60 years old with presumed PFO-associated stroke implanted with the Amplatzer™ PFO Occluder or the Amplatzer™ Talisman™ PFO Occluder.

Download

Related Resources

LAAO Summit 2023: Leaks/DRT

Premiclose 2022: Transcatheter PDA closure

Irie's testimonial

Safety and efficacy of the Trevisio™ Delivery system

PremiClose 2024: Optimizing care

ESC 2023 HF Satellite Symposium

LAAO Summit 2022: Panel discussion - Session 3

PFO closure animated procedure

TRENDING TOPICS

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline